Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs757075712
rs757075712
0.710 GeneticVariation BEFREE Through clinical exome sequencing, we identified a homozygous missense variant (c.533C>T; p.Pro178Leu) in mitochondrial transcription factor A (TFAM) segregating in a consanguineous kindred of Colombian-Basque descent in which two siblings presented with IUGR, elevated transaminases, conjugated hyperbilirubinemia and hypoglycemia with progression to liver failure and death in early infancy. 27448789

2016

dbSNP: rs757075712
rs757075712
T 0.710 GeneticVariation CLINVAR

dbSNP: rs139194636
rs139194636
C 0.700 GeneticVariation CLINVAR

dbSNP: rs367956522
rs367956522
C 0.700 CausalMutation CLINVAR

dbSNP: rs757600616
rs757600616
A 0.700 GeneticVariation CLINVAR

dbSNP: rs139041445
rs139041445
0.010 GeneticVariation BEFREE Frequencies of different haplotypes of a genomic region with two overlapping insertion-deletion polymorphisms (indels; rs141023871 and rs139041445) were compared between patients and controls, as well as between patients with and without a severe form of disease (liver failure). 29893695

2019

dbSNP: rs738409
rs738409
0.010 GeneticVariation BEFREE PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age. 31527889

2019

dbSNP: rs886037843
rs886037843
0.010 GeneticVariation BEFREE A homozygous mutation located at Chr17: 62492543G>A in POLG2, resulting in R182W substitution in p55, was previously identified to cause mtDNA depletion and fatal hepatic liver failure. 30157269

2018

dbSNP: rs374661051
rs374661051
0.010 GeneticVariation BEFREE The patient has the same mutation (c.547C>T; p.Arg183Trp) as the first case and presented with neonatal lactic acidosis, hypoglycemia and severe episodes of liver failure. 28275242

2017

dbSNP: rs1799983
rs1799983
0.010 GeneticVariation BEFREE Hence, the iNOS C150T polymorphism and the eNOS G894T polymorphism and high levels of iNOS and eNOS are associated with an increased risk of HEV-related acute hepatitis and liver failure. 24215170

2014

dbSNP: rs3087374
rs3087374
0.010 GeneticVariation BEFREE A heterozygous POLG1 p.Q1236H mutation was related to valproate-induced liver failure without mtDNA depletion, whereas patients homozygous for POLG1 p.W748S and p.E1143G mutations had mtDNA depletion. 25065347

2014

dbSNP: rs4986790
rs4986790
0.010 GeneticVariation BEFREE The study included nine patients with cirrhosis and TLR4 D299G and/or T399I polymorphisms, and 10 wild-type patients matched for age, sex and degree of liver failure. 25516666

2014

dbSNP: rs4986791
rs4986791
0.010 GeneticVariation BEFREE The study included nine patients with cirrhosis and TLR4 D299G and/or T399I polymorphisms, and 10 wild-type patients matched for age, sex and degree of liver failure. 25516666

2014

dbSNP: rs2910164
rs2910164
0.010 GeneticVariation BEFREE In this study, we explored the biological significance of a single-nucleotide polymorphism (rs2910164) within the miR-146a gene in the risk of acquiring ACLF-HBV. 23292505

2013

dbSNP: rs3820998
rs3820998
0.010 GeneticVariation BEFREE Logistic analysis revealed that the single-nucleotide polymorphism (SNP) rs3820998 was significantly associated with susceptibility to ACLF-HBV (dominant model, OR 0.643, 95% CI 0.428,0.964, p=0.033; additive model, OR 0.640, 95% CI 0.414,0.990, p=0.045), and LC (recessive model, OR 0.398, 95% CI 0.164,0.966, p=0.042; additive model, OR 0.379, 95% CI 0.155,0.928, p=0.034). 22225470

2012

dbSNP: rs1448427
rs1448427
0.010 GeneticVariation BEFREE Among these SNPs, rs1448427 was also significantly associated with the severe progression to end-stage hepatic failure in the replication study of PBC patients who underwent liver transplantation (PBC cohort II). 21116829

2011

dbSNP: rs1012335
rs1012335
0.010 GeneticVariation BEFREE The C allele at both loci was a susceptibility allele for ACLF-HBV and HCC, with the highest ORs reaching 1.653 (95% CI = 1.233, 2.216; p < 0.01 at rs1012335) in the ACLF-HBV group, and 1.659 (95% CI = 1.274, 2.159; p < 0.01 at rs1012335) in the HCC group. 20565290

2010

dbSNP: rs113994097
rs113994097
0.010 GeneticVariation BEFREE Four children, 2 related and 2 unrelated, with the novel p.P1073L mutation (all patients) and either the p.A467T (2 patients), p.G848S (1 patient), or p.W748S (1 patient) mutation presented with psychomotor delay, encephalopathy, and liver failure. 20142534

2010

dbSNP: rs113994098
rs113994098
0.010 GeneticVariation BEFREE Four children, 2 related and 2 unrelated, with the novel p.P1073L mutation (all patients) and either the p.A467T (2 patients), p.G848S (1 patient), or p.W748S (1 patient) mutation presented with psychomotor delay, encephalopathy, and liver failure. 20142534

2010

dbSNP: rs2257167
rs2257167
0.010 GeneticVariation BEFREE In comparison with the G/G genotype, the C/G and C/C genotypes at both single-nucleotide polymorphism (SNP) sites (rs1012335 and rs2257167) showed significant susceptibility to ACLF-HBV (the highest odds ratio [OR] reached 2.374; 95% CI = 1.488, 3.788; p < 0.001 for the C/G genotype at rs2257167), as well as HCC (OR = 2.475; 95% CI = 1.435, 4.426; p < 0.001 for the C/C genotype at rs1012335). 20565290

2010

dbSNP: rs267606959
rs267606959
0.010 GeneticVariation BEFREE Four children, 2 related and 2 unrelated, with the novel p.P1073L mutation (all patients) and either the p.A467T (2 patients), p.G848S (1 patient), or p.W748S (1 patient) mutation presented with psychomotor delay, encephalopathy, and liver failure. 20142534

2010